Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


08.05.2017

2 Am J Surg
1 Ann Thorac Surg
1 BMC Cancer
2 BMC Surg
6 Cancer
12 Dis Esophagus
1 Head Neck
1 HNO
13 Int J Cancer
2 J Clin Endocrinol Metab
1 J Clin Oncol
4 J Nucl Med
15 J Oral Maxillofac Surg
5 Laryngoscope
1 PLoS One
1 Radiother Oncol
1 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg

  1. JHA CK, Yadav SK, Bichoo RA
    Letter to editor in response to article entitled "Recurrence in patients with clinically early-stage papillary thyroid carcinoma according to tumor size surgical extent" by Kim JW et al published in Am J Surg. 2016 Sep;212(3):419-425.e1. doi: 10.1016/
    Am J Surg. 2016 Oct 11. pii: S0002-9610(16)30612.
    PubMed     Text format    

  2. OKI S, Toiyama Y, Okugawa Y, Shimura T, et al
    Clinical burden of preoperative albumin-globulin ratio in esophageal cancer patients.
    Am J Surg. 2017 Apr 25. pii: S0002-9610(16)30728.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  3. GAO SJ, Park HS, Corso CD, Rutter CE, et al
    Role of Adjuvant Treatment in Esophageal Cancer With Incidental Pathologic Node Positivity.
    Ann Thorac Surg. 2017 Apr 26. pii: S0003-4975(17)30206.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. ZHAO H, Wang Y, Wang MJ, Zhang ZH, et al
    Influence of presence/absence of thyroid gland on the cutoff value for thyroglobulin in lymph-node aspiration to detect metastatic papillary thyroid carcinoma.
    BMC Cancer. 2017;17:296.
    PubMed     Text format     Abstract available


    BMC Surg

  5. SIOW SL, Mahendran HA, Wong CM, Milaksh NK, et al
    Laparoscopic T-tube feeding jejunostomy as an adjunct to staging laparoscopy for upper gastrointestinal malignancies: the technique and review of outcomes.
    BMC Surg. 2017;17:25.
    PubMed     Text format     Abstract available

  6. CAVALLIN F, Alfieri R, Scarpa M, Cagol M, et al
    Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study.
    BMC Surg. 2017;17:49.
    PubMed     Text format     Abstract available


    Cancer

  7. NAIK KB, Liu Y, Goodman M, Gillespie TW, et al
    Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
    Cancer. 2017 May 2. doi: 10.1002/cncr.30763.
    PubMed     Text format     Abstract available

  8. PAI SI, Faquin WC
    Programmed cell death ligand 1 as a biomarker in head and neck cancer.
    Cancer. 2017 May 4. doi: 10.1002/cncy.21872.
    PubMed     Text format    

  9. HORNE ZD, Glaser SM, Vargo JA, Ferris RL, et al
    Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
    Cancer. 2016;122:2021-30.
    PubMed     Text format     Abstract available

  10. KU GY, Kriplani A, Janjigian YY, Kelsen DP, et al
    Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma.
    Cancer. 2016;122:2083-90.
    PubMed     Text format     Abstract available

  11. BISHOP JA, French CA, Ali SZ
    Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients.
    Cancer. 2016;124:901-908.
    PubMed     Text format     Abstract available

  12. JIANG XS, Harrison GP, Datto MB
    Young investigator challenge: Molecular testing in noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
    Cancer. 2016 Nov 28. doi: 10.1002/cncy.21802.
    PubMed     Text format     Abstract available


    Dis Esophagus

  13. JI WH, Jiang YH, Ji YL, Li B, et al
    Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
    Dis Esophagus. 2016;29:403-11.
    PubMed     Text format     Abstract available

  14. LI B, Tang SP, Wang KZ
    Esophagus cancer and occupational exposure to asbestos: results from a meta-analysis of epidemiology studies.
    Dis Esophagus. 2016;29:421-8.
    PubMed     Text format     Abstract available

  15. WAN J, Wu W, Che Y, Kang N, et al
    Insights into the potential use of microRNAs as a novel class of biomarkers in esophageal cancer.
    Dis Esophagus. 2016;29:412-20.
    PubMed     Text format     Abstract available

  16. MORI K, Yamagata Y, Aikou S, Nishida M, et al
    Short-term outcomes of robotic radical esophagectomy for esophageal cancer by a nontransthoracic approach compared with conventional transthoracic surgery.
    Dis Esophagus. 2016;29:429-34.
    PubMed     Text format     Abstract available

  17. WANG BJ, Zhang B, Yan SS, Li ZC, et al
    Hormonal and reproductive factors and risk of esophageal cancer in women: a meta-analysis.
    Dis Esophagus. 2016;29:448-54.
    PubMed     Text format     Abstract available

  18. SUNDE B, Ericson J, Kumagai K, Lundell L, et al
    Relief of dysphagia during neoadjuvant treatment for cancer of the esophagus or gastroesophageal junction.
    Dis Esophagus. 2016;29:442-7.
    PubMed     Text format     Abstract available

  19. HAVERKAMP L, Parry K, van Berge Henegouwen MI, van Laarhoven HW, et al
    Esophageal and Gastric Cancer Pearl: a nationwide clinical biobanking project in the Netherlands.
    Dis Esophagus. 2016;29:435-41.
    PubMed     Text format     Abstract available

  20. RICE TW, Ishwaran H, Hofstetter WL, Kelsen DP, et al
    Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.
    Dis Esophagus. 2016;29:897-905.
    PubMed     Text format     Abstract available

  21. RICE TW, Ishwaran H, Blackstone EH, Hofstetter WL, et al
    Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.
    Dis Esophagus. 2016;29:913-919.
    PubMed     Text format     Abstract available

  22. RICE TW, Ishwaran H, Kelsen DP, Hofstetter WL, et al
    Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.
    Dis Esophagus. 2016;29:906-912.
    PubMed     Text format     Abstract available

  23. SHAH IA, Bhat GA, Mehta P, Lone MM, et al
    Genotypes of CYP1A1, SULT1A1 and SULT1A2 and risk of squamous cell carcinoma of esophagus: outcome of a case-control study from Kashmir, India.
    Dis Esophagus. 2016;29:937-943.
    PubMed     Text format     Abstract available

  24. ZHAN C, Yan L, Wang L, Jiang W, et al
    Landscape of expression profiles in esophageal carcinoma by The Cancer Genome Atlas data.
    Dis Esophagus. 2016;29:920-928.
    PubMed     Text format     Abstract available


    Head Neck

  25. HINSON AM, Massoll NA, Jolly LA, Stack BC Jr, et al
    Structural alterations in tumor-draining lymph nodes before papillary thyroid carcinoma metastasis.
    Head Neck. 2017 May 3. doi: 10.1002/hed.24807.
    PubMed     Text format     Abstract available


    HNO

  26. SEND T, Kreppel B, Gaertner FC, Bundschuh RA, et al
    [PET-CT in head and neck cancer].
    HNO. 2017 Apr 27. doi: 10.1007/s00106-017-0355.
    PubMed     Text format     Abstract available


    Int J Cancer

  27. OGHUMU S, Knobloch TJ, Terrazas C, Varikuti S, et al
    Deletion of macrophage migration inhibitory factor inhibits murine oral carcinogenesis: Potential role for chronic pro-inflammatory immune mediators.
    Int J Cancer. 2016;139:1379-90.
    PubMed     Text format     Abstract available

  28. VAN DIJK BA, Brands MT, Geurts SM, Merkx MA, et al
    Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands.
    Int J Cancer. 2016;139:574-83.
    PubMed     Text format     Abstract available

  29. GUO T, Gaykalova DA, Considine M, Wheelan S, et al
    Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2016;139:373-82.
    PubMed     Text format     Abstract available

  30. AL-HEBSHI NN, Li S, Nasher AT, El-Setouhy M, et al
    Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes.
    Int J Cancer. 2016;139:363-72.
    PubMed     Text format     Abstract available

  31. BROTHERTON JM, Jit M, Gravitt PE, Brisson M, et al
    Eurogin Roadmap 2015: How has HPV knowledge changed our practice: vaccines.
    Int J Cancer. 2016 Feb 24. doi: 10.1002/ijc.30063.
    PubMed     Text format     Abstract available

  32. BODELON C, Untereiner ME, Machiela MJ, Vinokurova S, et al
    Genomic characterization of viral integration sites in HPV-related cancers.
    Int J Cancer. 2016 Jun 25. doi: 10.1002/ijc.30243.
    PubMed     Text format     Abstract available

  33. MCCORMACK VA, Menya D, Munishi MO, Dzamalala C, et al
    Informing etiologic research priorities for squamous cell esophageal cancer in Africa: A review of setting-specific exposures to known and putative risk factors.
    Int J Cancer. 2017;140:259-271.
    PubMed     Text format     Abstract available

  34. MILLRUD CR, Kagedal A, Kumlien Georen S, Winqvist O, et al
    NET-producing CD16high CD62Ldim neutrophils migrate to tumor sites and predict improved survival in patients with HNSCC.
    Int J Cancer. 2017;140:2557-2567.
    PubMed     Text format     Abstract available

  35. FRANK C, Sundquist J, Yu H, Hemminki A, et al
    Concordant and discordant familial cancer: Familial risks, proportions and population impact.
    Int J Cancer. 2017;140:1510-1516.
    PubMed     Text format     Abstract available

  36. BRUSSELAERS N, Maret-Ouda J, Konings P, El-Serag HB, et al
    Menopausal hormone therapy and the risk of esophageal and gastric cancer.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30588.
    PubMed     Text format     Abstract available

  37. LEVINGSTON CA, Young MR
    Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD-1 antibodies.
    Int J Cancer. 2017;140:1609-1619.
    PubMed     Text format     Abstract available

  38. LIEDERBACH E, Kyrillos A, Wang CH, Liu JC, et al
    The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma.
    Int J Cancer. 2017;140:504-512.
    PubMed     Text format     Abstract available

  39. PIETRANTONIO F, Caporale M, Morano F, Scartozzi M, et al
    HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research.
    Int J Cancer. 2016;139:2859-2864.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  40. PARK S, Jeon MJ, Song E, Oh HS, et al
    Clinical Features of Early and Late Postoperative Hypothyroidism after Lobectomy.
    J Clin Endocrinol Metab. 2017 Jan 11. doi: 10.1210/jc.2016-3597.
    PubMed     Text format     Abstract available

  41. CHOKSI P, Papaleontiou M, Guo C, Worden F, et al
    Skeletal Complications and Mortality in Thyroid Cancer: A Population-Based Study.
    J Clin Endocrinol Metab. 2017 Jan 25. doi: 10.1210/jc.2016-3906.
    PubMed     Text format     Abstract available


    J Clin Oncol

  42. SZTURZ P, Seiwert TY, Vermorken JB
    How Standard Is Second-Line Cetuximab in Recurrent or Metastatic Head and Neck Cancer in 2017?
    J Clin Oncol. 2017 May 4:JCO2016718072. doi: 10.1200/JCO.2016.71.8072.
    PubMed     Text format    


    J Nucl Med

  43. LIN CM, Yeh PT, Doyle P, Tsan YT, et al
    Association between 131I treatment for thyroid cancer and risk of receiving cataract surgery-a cohort study from Taiwan.
    J Nucl Med. 2016 Feb 2. pii: jnumed.115.167197.
    PubMed     Text format     Abstract available

  44. WIERTS R, Brans B, Havekes B, Kemerink G, et al
    Dose-response Relationship in Differentiated Thyroid Cancer Patients Undergoing Radioiodine Treatment Assessed by Means of 124I PET/CT.
    J Nucl Med. 2016 Feb 25. pii: jnumed.115.168799.
    PubMed     Text format     Abstract available

  45. RUHLMANN M, Jentzen W, Ruhlmann V, Pettinato C, et al
    High Level of Agreement between Pretherapeutic 124I PET and Intratherapeutic 131I Images in Detecting Iodine-positive Thyroid Cancer Metastases.
    J Nucl Med. 2016 May 5. pii: jnumed.115.169649.
    PubMed     Text format     Abstract available

  46. YANG X, Li J, Li X, Liang Z, et al
    TERT promoter mutation predicts radioiodine refractory in distant metastatic differentiated thyroid cancer.
    J Nucl Med. 2016 Aug 4. pii: jnumed.116.180240.
    PubMed     Text format     Abstract available


    J Oral Maxillofac Surg

  47. SHAH D, Hoffman GR
    Outcome of Head and Neck Cancer Patients Who Did Not Receive Curative-Intent Treatment.
    J Oral Maxillofac Surg. 2017 Apr 6. pii: S0278-2391(17)30369.
    PubMed     Text format     Abstract available

  48. MELVILLE JC, Stackowicz DJ, Jundt JS, Shum JW, et al
    Use of Botox (OnabotulinumtoxinA) for the Treatment of Parotid Sialocele and Fistula After Extirpation of Buccal Squamous Cell Carcinoma With Immediate Reconstruction Using Microvascular Free Flap: A Report of 3 Cases.
    J Oral Maxillofac Surg. 2016;74:1678-86.
    PubMed     Text format     Abstract available

  49. ZHANG GZ, Su T, Xu JM, Cheng ZQ, et al
    Clinical Retrospective Analysis of 9 Cases of Intraparotid Facial Nerve Schwannoma.
    J Oral Maxillofac Surg. 2016;74:1695-705.
    PubMed     Text format     Abstract available

  50. ETTINGER KS, Moore EJ, Lohse CM, Reiland MD, et al
    Application of the Surgical Apgar Score to Microvascular Head and Neck Reconstruction.
    J Oral Maxillofac Surg. 2016;74:1668-77.
    PubMed     Text format     Abstract available

  51. TIAN Y, Xu DP, Tong S, Xi SL, et al
    Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
    J Oral Maxillofac Surg. 2016;74:1623-9.
    PubMed     Text format     Abstract available

  52. ROSTETTER C, Kuster IM, Schenkel JS, Lanzer M, et al
    The Effects of Preoperative Radiotherapy on Head and Neck Free Flap Anastomosis Success.
    J Oral Maxillofac Surg. 2016;74:2521-2525.
    PubMed     Text format     Abstract available

  53. MURPHY J, Berman DR, Edwards SP, Prisciandaro J, et al
    Squamous Cell Carcinoma of the Tongue During Pregnancy: A Case Report and Review of the Literature.
    J Oral Maxillofac Surg. 2016;74:2557-2566.
    PubMed     Text format     Abstract available

  54. LIN SL, Wu SL, Tsai CC, Ko SY, et al
    The Use of Solid-Phase Concentrated Growth Factors for Surgical Defects in the Treatment of Dysplastic Lesions of the Oral Mucosa.
    J Oral Maxillofac Surg. 2016;74:2549-2556.
    PubMed     Text format     Abstract available

  55. KOSEC A, Vucic M, Bedekovic V, Ivkic M, et al
    Osteoblastic Extraosseous Osteosarcoma of the Neck.
    J Oral Maxillofac Surg. 2017;75:650.
    PubMed     Text format     Abstract available

  56. TAGA T, Nonaka T, Manabe T, Bessho K, et al
    Exophytic Tumor Growth After Incomplete Removal of Polypoid Malignant Melanoma of the Maxillary Gingiva: A Case Report and Review of the Literature.
    J Oral Maxillofac Surg. 2016;74:2328.
    PubMed     Text format     Abstract available

  57. MA C, Li X, Li Y, Qu X, et al
    Primary Ectopic Meningioma of the Tongue: Case Report and Review of the Literature.
    J Oral Maxillofac Surg. 2016;74:2216-2228.
    PubMed     Text format     Abstract available

  58. MARWAN H, Green JM 3rd, Tursun R, Marx RE, et al
    Recurrent Malignancy in Osteoradionecrosis Specimen.
    J Oral Maxillofac Surg. 2016;74:2312-2316.
    PubMed     Text format     Abstract available

  59. CHEN WL, Yang ZH, Huang ZQ, Fan S, et al
    Craniofacial Resection and Reconstruction in Patients With Recurrent Cancer Involving the Craniomaxillofacial Region.
    J Oral Maxillofac Surg. 2017;75:622-631.
    PubMed     Text format     Abstract available

  60. ROHRBACH MR, Britt CJ, Schwalbe M, Wieland AM, et al
    p16 Immunohistochemistry Is a Useful Diagnostic Adjunct in Cases of Metastatic Cervical Carcinoma of Unknown Origin.
    J Oral Maxillofac Surg. 2017;75:525-529.
    PubMed     Text format     Abstract available

  61. THEOCHARIS S, Giaginis C, Dana E, Thymara I, et al
    Phosphorylated Epidermal Growth Factor Receptor Expression Is Associated With Clinicopathologic Parameters and Patient Survival in Mobile Tongue Squamous Cell Carcinoma.
    J Oral Maxillofac Surg. 2017;75:632-640.
    PubMed     Text format     Abstract available


    Laryngoscope

  62. SOMMAT K, Yit NL, Kwok LL
    Comparison between 4-MV and 6-MV radiotherapy in T1N0 glottic cancer.
    Laryngoscope. 2017;127:1061-1067.
    PubMed     Text format     Abstract available

  63. WORTHEN M, Jusufbegovic M, Bumpous JM, Vaughn A, et al
    Fungal contribution in chondroradionecrosis of the larynx.
    Laryngoscope. 2017;127:E159-E165.
    PubMed     Text format     Abstract available

  64. PLATEK ME, Jayaprakash V, Gupta V, Cohan DM, et al
    Subsite variation in survival of oropharyngeal squamous cell carcinomas 2004 to 2011.
    Laryngoscope. 2017;127:1087-1092.
    PubMed     Text format     Abstract available

  65. DIN HA, Zhan KY, Boling C, Nguyen S, et al
    Predictors of survival in posterior cricoid squamous cell carcinoma: A study of 248 cases.
    Laryngoscope. 2017;127:1093-1096.
    PubMed     Text format     Abstract available

  66. THOMAS GR, Lo K, Nwojo R
    Human papillomavirus-induced oropharyngeal cancer in Hispanics in the United States.
    Laryngoscope. 2017;127:1097-1101.
    PubMed     Text format     Abstract available


    PLoS One

  67. WANG F, Ding X, Wang T, Shan Z, et al
    Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin.
    PLoS One. 2017;12:e0174276.
    PubMed     Text format     Abstract available


    Radiother Oncol

  68. LIN SH, Merrell KW, Shen J, Verma V, et al
    Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer.
    Radiother Oncol. 2017 Apr 25. pii: S0167-8140(17)30154.
    PubMed     Text format     Abstract available


    Thyroid

  69. KIM M, Kim WG, Park S, Kwon H, et al
    Growth Kinetics of Macronodular Lung Metastases and Survival in Differentiated Thyroid Carcinoma.
    Thyroid. 2017 May 2. doi: 10.1089/thy.2016.0676.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: